SCHEMBL5336971

SCHEMBL5336971

CCOC(=O)C1COc2cc3ccccc3cc2O1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.59
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 4/20 0.50
HPGD P15428 4/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
CYP2C19 P33261 1/20 0.50
L3MBTL1 Q9Y468 3/20 0.48
GAA P10253 3/20 0.48
LMNA P02545 2/20 0.48
TSHR P16473 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11465271 0.87 CYP4F2 (0.49) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL612174 0.85 TSHR (0.63) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL1519306 0.84 POLB (0.48) POLBALDH1A1KDM4EMAPTKMT2A
SCHEMBL22397032 0.84 ATM (0.48) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL1519333 0.82 CYP4F2 (0.50) POLBALDH1A1KDM4EHPGDL3MBTL1
SCHEMBL1519271 0.82 CYP4F2 (0.50) POLBALDH1A1KDM4EHPGDL3MBTL1
SCHEMBL11446908 0.82 L3MBTL1 (0.47) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL11454486 0.82 L3MBTL1 (0.47) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL7204613 0.80 CYP4F2 (0.46) POLBALDH1A1HPGDKMT2AMEN1
SCHEMBL9254561 0.80 CYP4F2 (0.46) POLBALDH1A1HPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202255-B2 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2007-04-10 US disclosed
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same CYP11B2, CYP2F1, CYP3A43 POLB 2793/4885ALDH1A1 943/4885KDM4E 4183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.